ConductScience.org, home
To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
API referenceFor AI assistants

Trial · NCT01068860

Participant flow30

How many started, completed or left each group, period by period.

1 to 20 of 30

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDCanakinumab 150 mg + Metformin33
Overall StudySTARTEDPlacebo + Metformin17
Overall StudySTARTEDCanakinumab 150 mg + Metformin + Sulfonylurea33
Overall StudySTARTEDPlacebo + Metformin + Sulfonylurea17
Overall StudySTARTEDCanakinumab 150 mg Canakinumab 150 mg + Met + Sulfonyl + Thia32
Overall StudySTARTEDPlacebo + Met + Sulfonyl + Thiaz16
Overall StudySTARTEDCanakinumab 150 mg + Insulin28
Overall StudySTARTEDPlacebo + Insulin15
Overall StudySTARTEDCanakinumab 150 mg in Participants With IGT28
Overall StudySTARTEDPlacebo in Participants With IGT27
Overall StudyCOMPLETEDCanakinumab 150 mg + Metformin33
Overall StudyCOMPLETEDPlacebo + Metformin16
Overall StudyCOMPLETEDCanakinumab 150 mg + Metformin + Sulfonylurea33
Overall StudyCOMPLETEDPlacebo + Metformin + Sulfonylurea16
Overall StudyCOMPLETEDCanakinumab 150 mg Canakinumab 150 mg + Met + Sulfonyl + Thia32
Overall StudyCOMPLETEDPlacebo + Met + Sulfonyl + Thiaz14
Overall StudyCOMPLETEDCanakinumab 150 mg + Insulin28
Overall StudyCOMPLETEDPlacebo + Insulin15
Overall StudyCOMPLETEDCanakinumab 150 mg in Participants With IGT28
Overall StudyCOMPLETEDPlacebo in Participants With IGT23

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Next page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01068860/flow

API referenceFor AI assistants